{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:05:17Z","timestamp":1792202717301,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eclinm.2023.102370","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:59:08Z","timestamp":1702670348000},"page":"102370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4834-8085","authenticated-orcid":false,"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-0882","authenticated-orcid":false,"given":"Zhengwei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9844","key":"10.1016\/j.eclinm.2023.102370_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.102370_bib2","article-title":"Non-Hodgkin lymphoma","volume":"362","author":"Bowzyk Al-Naeeb","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102370_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102370_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3816\/CLM.2003.n.025","article-title":"An update of the epidemiology of non-Hodgkin's lymphoma","volume":"4","author":"Chiu","year":"2003","journal-title":"Clin Lymphoma"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102370_bib5","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2542-5196(21)00149-2","article-title":"Benzene exposure and non-Hodgkin lymphoma: a systematic review and meta-analysis of human studies","volume":"5","author":"Rana","year":"2021","journal-title":"Lancet Planet Health"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"Muller","year":"2005","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib7","first-page":"5","article-title":"Epidemiology of non-hodgkin's lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci"},{"issue":"48","key":"10.1016\/j.eclinm.2023.102370_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/jncimonographs\/lgu003","article-title":"Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma\/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Mbulaiteye","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib9","article-title":"Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vdelta2(+) T cells activities after hematopoietic transplantation for blood malignancies","volume":"8","author":"Liu","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102370_bib10","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood.V81.10.2810.2810","article-title":"Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen","volume":"81","author":"Sparano","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2023.102370_bib11","series-title":"Fact sheet - latest global and regional statistics on the status of the AIDS epidemic","year":"2023"},{"key":"10.1016\/j.eclinm.2023.102370_bib12","series-title":"HIV estimates with uncertainty bounds 1990-Present","year":"2023"},{"key":"10.1016\/j.eclinm.2023.102370_bib13","series-title":"90-90-90 \u2013 an ambitious treatment target to help end the AIDS epidemic","year":"2014"},{"issue":"10144","key":"10.1016\/j.eclinm.2023.102370_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","article-title":"Advancing global health and strengthening the HIV response in the era of the sustainable development goals: the international AIDS society-lancet commission","volume":"392","author":"Bekker","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002729","article-title":"Progress in the HIV epidemic: identifying goals and measuring success","volume":"16","author":"Jones","year":"2019","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102370_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/cid\/ciac925","article-title":"Age and cancer incidence in 5.2 million people with human immunodeficiency virus (HIV): the South African HIV cancer match study","volume":"76","author":"Ruffieux","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102370_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2023.102370_bib18","first-page":"31","article-title":"HIV\/AIDS associated lymphoma: review","volume":"12","author":"Berhan","year":"2022","journal-title":"Blood Lymphat Cancer"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102370_bib19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102370_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(19)30470-0","article-title":"Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data","volume":"20","author":"Looker","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102370_bib21","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/STROKEAHA.123.043410","article-title":"Global and regional estimate of HIV-associated stroke burden: a meta-analysis and population attributable modeling study","volume":"54","author":"Yang","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.eclinm.2023.102370_bib22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2023.102370_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2023.102370_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"Rover","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102370_bib25","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2023.102370_bib26","series-title":"Modern epidemiology","author":"Kenneth","year":"2008"},{"issue":"17","key":"10.1016\/j.eclinm.2023.102370_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bjsports-2020-101977","article-title":"Methods matter: population attributable fraction (PAF) in sport and exercise medicine","volume":"54","author":"Khosravi","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.eclinm.2023.102370_bib28","article-title":"Population attributable fraction in textbooks: time to revise","volume":"3","author":"Khosravi","year":"2021","journal-title":"Glob Epidemiol"},{"key":"10.1016\/j.eclinm.2023.102370_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/RMHP.S265887","article-title":"Estimation of generalized impact fraction and population attributable fraction of hypertension based on JNC-IV and 2017 ACC\/AHA guidelines for cardiovascular diseases using parametric G-formula: tehran lipid and glucose study (TLGS)","volume":"13","author":"Saatchi","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/wps.21068","article-title":"Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction","volume":"22","author":"Dragioti","year":"2023","journal-title":"World Psychiatry"},{"issue":"10258","key":"10.1016\/j.eclinm.2023.102370_bib31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib32","first-page":"31","article-title":"Partitioning linear trends in age-adjusted rates","volume":"11","author":"Hankey","year":"2000","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102370_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000456036","article-title":"HIV-associated malignant lymphoma","volume":"40","author":"Brunnberg","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102370_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8885","key":"10.1016\/j.eclinm.2023.102370_bib35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0140-6736(93)92931-I","article-title":"Role of HTLV-I in development of non-hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV lymphoma study group","volume":"342","author":"Manns","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102370_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nrgastro.2010.58","article-title":"Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development","volume":"7","author":"Sagaert","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2023.102370_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.immunol.21.120601.141053","article-title":"T\u00a0cell dynamics in HIV-1 infection","volume":"21","author":"Douek","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102370_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1189\/jlb.72.3.429","article-title":"The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses","volume":"72","author":"Mahalingam","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102370_bib39","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/ni1125","article-title":"Intrinsic immunity: a front-line defense against viral attack","volume":"5","author":"Bieniasz","year":"2004","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102370_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-8588(03)00050-9","article-title":"Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma","volume":"17","author":"Knowles","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.eclinm.2023.102370_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0065-230X(08)60712-5","article-title":"Molecular pathogenesis of AIDS-related lymphomas","volume":"67","author":"Gaidano","year":"1995","journal-title":"Adv Cancer Res"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102370_bib42","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1084\/jem.164.6.2049","article-title":"Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis","volume":"164","author":"Pelicci","year":"1986","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102370_bib43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood.V72.2.667.667","article-title":"Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma","volume":"72","author":"Subar","year":"1988","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102370_bib44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.cco.0000239882.23839.e5","article-title":"Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions","volume":"18","author":"Epeldegui","year":"2006","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102370_bib45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ccr.2010.11.024","article-title":"Constitutive canonical NF-kappaB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma","volume":"18","author":"Calado","year":"2010","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102370_bib46","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0000000000000986","article-title":"Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy","volume":"30","author":"Olszewski","year":"2016","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102370_bib47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ijc.33840","article-title":"Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012 to 2018","volume":"150","author":"Mpunga","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/apm.12078","article-title":"Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009","volume":"122","author":"Mbulaiteye","year":"2014","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102370_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4269\/ajtmh.19-0144","article-title":"Rapid HIV antigen-antibody assays and detection of acute HIV infection in sub-saharan Africa","volume":"101","author":"Adetunji","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102370_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/COH.0000000000000334","article-title":"Combination antiretroviral therapy and cancer risk","volume":"12","author":"Borges","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.eclinm.2023.102370_bib51","series-title":"Global HIV & AIDS statistics \u2014 fact sheet","year":"2022"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102370_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A\u00a0review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102370_bib53","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(04)01650-X","article-title":"Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?","volume":"5","author":"van den Bosch","year":"2004","journal-title":"Lancet Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.eclinm.2023.102370_bib54","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/bjc.2011.484","article-title":"Cancers attributable to infection in the UK in 2010","volume":"105 Suppl 2","author":"Parkin","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eclinm.2023.102370_bib55","series-title":"Country factsheets South Africa 2021","year":"2021"},{"key":"10.1016\/j.eclinm.2023.102370_bib56","first-page":"44","article-title":"Hepatitis C virus (HCV) infection in Africa: a review","volume":"14","author":"Karoney","year":"2013","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.eclinm.2023.102370_bib57","series-title":"UNAIDS data 2020","year":"2020"},{"issue":"107","key":"10.1016\/j.eclinm.2023.102370_bib58","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102370_bib59","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1021\/acs.molpharmaceut.2c01080","article-title":"Recent updates on viral oncogenesis: available preventive and therapeutic entities","volume":"20","author":"Chowdhary","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.eclinm.2023.102370_bib60","series-title":"UNAIDS data 2022","year":"2022"},{"key":"10.1016\/j.eclinm.2023.102370_bib61","series-title":"In danger: UNAIDS global AIDS update 2022","year":"2022"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102370_bib62","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102370_bib63","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hernandez-Ramirez","year":"2017","journal-title":"Lancet HIV"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:23:09Z","timestamp":1762899789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023005473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":63,"alternative-id":["S2589537023005473"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102370","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102370"}}